Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

This fun logo quiz features five challenging rounds, and includes themed rounds on car logos, food companies and fashion brands. If there’s one thing lockdown taught us, it was that quizzes were a ...

After years of declining enrollment, the Philadelphia School District has grown. Superintendent Tony B. Watlington Sr. said the school system’s official student count for 2024-25 is 117,956 — 1,841 ...

Dual enrollment is allowed in one full-time physical course and another through Open and Distance Learning (ODL) or online mode. Only UGC-recognised institutions can offer degree or diploma ...

The new logo emphasized the brand's posh English pronunciation "Jag-you-are". Prior to its relaunch as an electric-only brand, luxury car manufacturer Jaguar announced its 'new era ' by unveiling ...

The video starts with a closed elevator and the debut of the new logo appearing. Eight models wearing vibrant colors walk out of the elevator and are featured throughout the clip. Many social ...

When the superintendent in San Francisco Unified proposed closing schools recently, parents launched a prolonged — and successful — protest. The uproar may have died down for now, but the ...

Jaguar has unveiled a new logo that emphasizes its posh British pronunciation as it transitions into a “new era” that emphasizes its upcoming all-electric vehicle lineup. The 102-year-old ...

1 MBA: Students who enroll in a qualifying undergraduate degree have the opportunity to add an MBA to their bachelor’s degree after their first year of study, depending on their program. Learn how the ...

A Phase 2 clinical trial of TX45, Tectonic Therapeutic’s investigational therapy for pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), has begun enrolling eligible ...

An update from Armata Pharmaceuticals ( (ARMP)) is now available. Armata Pharmaceuticals has announced the full enrollment of its Phase 1b/2a diSArm study, evaluating the intravenous AP-SA02 as a ...